Definitive Healthcare Corp. (DH)
Healthcare • Health Information Services • $1.08 • MCap: 106,744,712
https://www.definitivehc.com • Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, marketing and advertising agencies.Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
Watch List
| Score | Price | 52 Week & Averages | Relative Strength | Risk | |||||
|---|---|---|---|---|---|---|---|---|---|
| Total | 42 | Current | $1.08 | 52W High | $2.97 -63.64% | Relative Strength | 0.01 | Beta | 1.40 |
| Business Quality | 10 | Weekly | $1.00 8.43% | 52W Low | $0.63 71.97% | 3M | 0.58 | Short % | 0.04 |
| Financial Strength | 7 | Monthly | $0.89 21.35% | Above 50DMA | $0.93 16.64% | 6M | 0.08 | Risk Score | 9 |
| Growth Outlook | 1 | Quarterly | $0.68 58.13% | Above 200DMA | $1.12 -3.60% | 9M | -0.56 | ||
| Momentum | 2 | Yearly | $2.97 -63.64% | 12M | -0.64 | ||||
| Valuation | Financial Strength | Growth/Profitability | |||
|---|---|---|---|---|---|
| Trailing P/E | N/A | Cash | 184M | Revenue Growth | -0.09% |
| Forward P/E | 5.36 | Debt | 167M | Earnings Growth | N/A |
| PEG Ratio | N/A | Debt/Equity | 88.92 | Qtr Earnings Growth | N/A |
| Price/Sales | 0.46 | Current Ratio | 1.86 | Gross Margin | 0.84% |
| Price/Book | 0.74 | Quick Ratio | 1.67 | Operating Margin | -0.09% |
| EV/Revenue | 0.57 | Operating CF | 41M | Profit Margin | -0.72% |
| EV/EBITDA | 3.77 | Free CF | 50M | EBITDA Margin | 0.15% |
| Ent Value | 133M | Return on Assets | -0.02% | ||
| Return on Equity | -0.78% | ||||
| Technical | Volume & Bollinger Bands | Analyst | |||
|---|---|---|---|---|---|
| RSI | 61.48 | Volume | 0.19M | Rating | none |
| Previous RSI | 74.60 | Avg Volume 20D | 0.44M | Target Mean | $1.90 |
| RSI Trend | Down | Relative Volume | 0.34 | Target High | $3.00 |
| MACD | 0.05 | Lower Band | 0.85 | Target Low | $1.00 |
| MACD Signal | 0.03 | Middle Band | 0.99 | Target Median | $1.50 |
| Histogram | 0.01 | Upper Band | 1.13 | Analysts | 5 |
| Previous Histogram | 0.02 | Bandwidth | 27.960 | Upside | 90.00% |
| Histogram Trend | Decreasing | %B | 0.82 | ||
